 |
|
Primary Prevention of Coronary Heart Disease in WomenShould Asymptomatic Women 50 Years of Age Take Aspirin Regularly?
Scott E. Woods, MD
Arch Fam Med. 1994;3(4):361-364.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Eaker E, Packard B, Thom T. Epidemiology and risk factors for coronary heart disease in women. In: Douglas P, ed. Heart Disease in Women. New York, NY: Davis Co; 1989:129-145. Cardiobascular Clinics Series No. 3.
2. Eaker E, Packard B, Wenger N, Clarkson T, Tyroler H, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987:190-194. 3. Wenger N. Coronary disease in women. Annu Rev Med. 1985;36:285-294.
PUBMED
4. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
ABSTRACT
5. Smith J, Willis A. Aspirin selectively inhibits prostaglandin production in human platelets. Nature. 1971;231:235-237.
6. Roth G, Majerus P. The mechanism of the effect of aspirin on human platelets. J Clin Invest. 1975;56:624-632.
PUBMED
7. Cairs J, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med. 1985;313:1369-1375.
ABSTRACT
8. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.
ABSTRACT
9. Aspirin after myocardial infarction. Lancet. 1980;1:1172-1173. Editorial.
PUBMED
10. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ. 1988;296:320-331.
FREE FULL TEXT
11. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
PUBMED
12. Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ. 1988;296:313-316.
FREE FULL TEXT
13. US Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. Baltimore, Md: Williams & Wilkins; 1989. 14. Hammond E, Garfinkel L. Aspirin and coronary heart disease. BMJ. 1975;2:269-271.
FREE FULL TEXT
15. Paganini-Hill A, Chao A, Ross R, Henderson B. Aspirin use and chronic diseases. BMJ. 1989;299:1247-1250.
FREE FULL TEXT
16. Manson J, Stampfer M, Colditz G, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA. 1991;226:521-527.
17. Everhart J, Knowler W, Bennett P. Incidence and risk factors for non-insulin-dependent diabetes. In: Diabetes in America. Rockville, Md: National Institutes of Health; 1985:iv-1. National Institutes of Health publication 85-1468. 18. Stampfer M, Colditz G, Willett W, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
ABSTRACT
19. Wolf P, Kannel W, McGee D. Epidemiology of strokes in North America. In: Mohr J, Barnett H, Stein B, Yatsu F, eds. Stroke. New York, NY: Churchill Livingstone Inc; 1986:23. 20. Hirsh J, Dalen J, Fuster V, et al. Aspirin and other platelet-active drugs. Chest. 1993;102(suppl_2):327S-336S.
|
